Numerous parallels can be drawn between the EU AI Act and product safety legislation - including risk classification for product liability, conformity assessments, CE marking and post-market surveillance – all of which are mirrored in the Act.

But are organisations that are well-versed in placing safety-critical products on the market, better prepared to comply with the product safety aspects of the EU AI Act than others?

In the second episode of our mini-series focusing on this significant regulatory change, host Anneke Pol is joined by Charlie Hawes and Alex Denoon to:

• Explore some of these parallels in more detail; and
• Share some takeaways from medical device legislation for those looking to comply with the product safety features of the Act – particularly in the context of “high risk” AI systems.

Please also take a look at our article series on the EU AI Act in which we address these subjects further – high risk AI, provider and deployer roles, product safety requirements, AI governance, and IP and employment issues under the Act.

Note: All information was correct at the time of recording.

Send us a text

Thanks for listening!
If you have any feedback, questions or comments, please email us at [email protected]

Find all the episodes as we release them here, and don’t forget to subscribe! Follow us on X and LinkedIn using #TheRoadmapPod